The allegations in the article include: Use of disallowed ingredients: "[use of] active pharmaceutical ingredients, or APIs, after it had failed quality control tests, including sterility tests"
Research indicates that stopping or interrupting obesity treatments, particularly weight-loss medications like GLP-1 drugs, frequently results in a rapid regain of lost weight
[1] [2] This weekly dosing schedule is consistent with other agents in the incretin-based therapy class, such as semaglutide and tirzepatide, and is designed to maintain stable drug levels in the body throughout the treatment period
Understanding this mechanism matters because it explains why most GI side effects are dose-dependent, temporary, and manageable through titration strategies
Homemade drinks help with detoxification and provide a mild natural glow, but they cannot deliver whitening because they lack actual glutathione
Insulin-like growth factor 1 (IGF-1): A growth hormone